XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Stockholders’ Equity - Schedule of Fair Value of Stock Options Valuation Assumptions

The estimated grant date fair value of stock option grants was calculated using the Black-Scholes-Merton option-pricing model using the following assumptions:

 

   2023   2022 
Weighted average volatility   181.29%   192.71%
Weighted average expected term (years)   5.00    5.00 
Risk free interest rate   4.53%   1.90%
Expected dividend yield            
Stockholders’ Equity - Schedule of Share-Based Compensation, Stock Option Activity

The following table represents incentive stock option activity as of and for the year ended December 31, 2023:

 

    Number of   Weighted Average   Weighted Average   Aggregate 
    Shares   Exercise Price   Remaining Life   Intrinsic Value 
                  
Options Outstanding – December 31, 2022    4,405,000   $.59    3.22   $2,260,138 
Granted    3,245,000    .86           
Exercised    (950,000)   .53           
Forfeited    (700,000)               
Options Outstanding – December 31, 2023    6,000,000   $.75    3.69   $872,463 
                      
Exercisable and Vested, December 31, 2023    641,155   $.50    1.58   $247,547 

 

The following table represents stock option activity as of and for the year ended December 31, 2022:

 

   

Number of

Shares

  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

  

Aggregate

Intrinsic Value

 
                  
Options Outstanding: December 31, 2021    4,260,000   $.37    2.25   $5,862,938 
Granted    900,000   $1.16           
Exercised    (625,000)   .17         920,750 
Forfeited    (130,000)               
Options Outstanding: December 31, 2022    4,405,000   $.59    3.22   $2,260,138 
                      
Exercisable and Vested: December 31, 2022    1,722,041   $.36    1.80   $1,271,653